Dutch Researchers Rank Higher than the Top 10 Most Research-Intensive Nations In Key Research Performance Areas

Elsevier analysis reveals that international collaboration and mobility push Dutch research performance to global top

Amsterdam, May 6, 2013

Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced the outcomes of a comparative study of Dutch researchers' international performance. The study, based on Scopus data and using Elsevier's SciVal research performance measurement tools, showed that in a comparison that includes the top 10 R&D spending nations in the world, the Netherlands ranks No. 1 in publication impact per article and number 1 by level of international collaboration.

Furthermore, within this group the Netherlands ranks number 1 in the world in citations generated per unit of R&D spending and number 2 in publications generated per unit of R&D spending. The figures were presented at the Impact of Science Conference held in Amsterdam.

Nick Fowler, Elsevier’s Managing Director of A&G Institutional Markets, said: “Two factors contribute to the success of the Netherlands: international collaboration and a geographically mobile research base. 48.7% of articles written by a Netherlands-based researcher are written in collaboration with a researcher outside the Netherlands. This is a higher proportion than any of the top 10 R&D-spending nations in the world. International collaboration is generally acknowledged as a positive force driving research impact and prestige. The second factor, the mobile research base, relates to what we call ‘brain circulation’, or cross-border mobility of researchers. The Netherlands has a history of allowing people to move in and out, also in the science world. For example no less than 74% of authors affiliated with Dutch institutions have also published at an institution in another country at some point in their careers. That hugely benefits Dutch research.”

# # #

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Harald Boersma
Elsevier
+31 20 485 2736
H.boersma@elsevier.com